Table 1 Clinicopathological characteristics of colorectal cancer patients according to age groups.

From: The prognostic factors and multiple biomarkers in young patients with colorectal cancer

Characteristic

WC

P

SEER

P

LC

P

 

≤50 years n = 530 (%)

>50 years n = 5388 (%)

 

≤50 years n = 43,236 (%)

>50 years n = 459,766 (%)

 

≤50 years n = 55 (%)

>50 years n = 959 (%)

 

Gender

 Male

232 (43.8)

3,333 (61.9)

<0.001

22,803 (52.7)

231,126 (50.3)

<0.001

24 (43.6)

525 (54.7)

0.108

 Female

298 (56.2)

2,055 (38.1)

 

20,433 (47.3)

228,640 (49.7)

 

31 (56.4)

434 (45.3)

 

Locationa

 Right Colon

65 (12.3)

1221 (22.7)

<0.001

16,021 (38.5)

171,793 (38.8)

<0.001

8 (14.5)

292 (30.4)

0.007

 Left Colon

86 (16.2)

780 (14.5)

 

13,074 (31.5)

139,756 (31.6)

 

16 (29.1)

154 (16.1)

 

 Rectum

379 (71.5)

3387 (62.8)

 

12,476 (30.0)

130,975 (29.6)

 

31 (56.4)

513 (53.5)

 

 Missing

0

0

 

1,665

17,242

 

0

0

 

Tumour numbers

 Single

185 (96.9)

995 (90.5)

0.006

35,423 (81.9)

313,627 (68.2)

<0.001

41 (95.3)

747 (94.3)

1.000

 Multiple

6 (3.1)

104 (9.5)

 

7,810 (18.1)

146,091 (31.8)

 

2 (4.7)

45 (5.7)

 

 Missing

339

4,289

 

3

48

 

12

167

 

TNM stageb

 I

72 (14.1)

1262 (23.6)

<0.001

6,495 (24.0)

70,291 (27.5)

<0.001

7 (13.0)

157 (16.8)

0.455

 II

115 (22.6)

1741 (32.5)

 

6,165 (22.8)

75,163 (29.4)

 

21 (38.9)

345 (37.0)

 

 III

144 (28.3)

1500 (28.0)

 

8,058 (29.7)

62,180 (24.3)

 

14 (25.9)

290 (31.1)

 

 IV

178 (35.0)

853 (15.9)

 

6,373 (23.5)

47,931 (18.8)

 

12 (22.2)

141 (15.1)

 

 Othersc

21

32

 

16,145

204,201

 

1

26

 

Tumour growth pattern

 Expansive

122 (40.8)

599 (28.5)

<0.001

/

/

 

15 (40.5)

356 (49.9)

0.269

 Infiltrative

177 (59.1)

1,503 (71.5)

 

/

/

 

22 (59.5)

358 (50.1)

 

 Missing

231

3,286

 

/

/

 

18

245

 

Histological type

 Non-mucinous

379 (71.5)

4173 (77.4)

0.002

36,931 (88.7)

391,999 (90.5)

<0.001

49 (90.7)

854 (90.2)

0.893

 Mucinousd

151 (28.5)

1215 (23.6)

 

4,694 (11.3)

41,114 (9.5)

 

5 (9.3)

93 (9.8)

 

 Others

0

0

 

1,611

26,653

 

1

12

 

Differentiatione

 Well

25 (5.7)

130 (2.7)

<0.001

4,112 (13.3)

49,038 (14.8)

<0.001

2 (3.7)

60 (6.3)

0.754

 Moderately

284 (64.5)

3502 (72.1)

 

20,013 (64.7)

217,711 (65.8)

 

36 (66.7)

626 (66.1)

 

 Poorly+undifferentiated

131 (29.8)

1226 (25.2)

 

6,811 (22)

64,133 (19.4)

 

16 (29.6)

261 (27.6)

 

 Missing

90

530

 

12,300

128,884

 

11

2

 

Surgical type

 Radical

518 (97.7)

5130 (95.2)

0.008

/

/

 

44 (80.0)

790 (84.8)

0.593

 Palliative+unresectable

12 (2.3)

258 (4.8)

 

/

/

 

11 (20.0)

164 (17.2)

 

 Missing

0

0

 

/

/

 

0

5

 

Radiotherapy

 No

/

/

 

35,153 (82.2)

412,124 (91.0)

<0.001

30 (69.8)

617 (79.1)

0.146

 Yes

/

/

 

7,622 (17.8)

40,814 (9.0)

 

13 (30.2)

163 (20.9)

 

 Missing

/

/

 

461

6,828

 

12

179

 

Chemotherapy

 No

/

/

 

/

/

 

42 (95.5)

694 (89.8)

0.221

 Yes

/

/

 

/

/

 

2 (4.5)

79 (10.2)

 

 Missing

/

/

 

/

/

 

11

186

 
  1. aRight colon vs. distal (left colon+rectum): P < 0.001, P = 0.007 and P = 0.012 in WC, SEER and LC, respectively.
  2. bStage I + II vs. III + IV: P < 0.001, P < 0.001 and P = 0.780 in WC, SEER and LC, respectively.
  3. cOthers include stage 0 and missing cases.
  4. dMucinous carcinoma includes signet-ring cell carcinoma.
  5. eWell + Moderately vs poorly+undifferentiated: P = 0.037, P < 0.001 and P = 0.741 in WC, SEER and LC, respectively.